These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25041142)

  • 1. Testosterone and mortality.
    Muraleedharan V; Jones TH
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):477-87. PubMed ID: 25041142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone and cardiovascular risk in men.
    Kelly DM; Jones TH
    Front Horm Res; 2014; 43():1-20. PubMed ID: 24943294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone deficiency.
    Traish AM; Miner MM; Morgentaler A; Zitzmann M
    Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between serum testosterone levels and features of the metabolic syndrome defining criteria in patients with type 2 diabetes mellitus.
    Ogbera AO
    West Afr J Med; 2011; 30(4):277-81. PubMed ID: 22669833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogonadism and metabolic syndrome: implications for testosterone therapy.
    Makhsida N; Shah J; Yan G; Fisch H; Shabsigh R
    J Urol; 2005 Sep; 174(3):827-34. PubMed ID: 16093964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related androgen deficiency and type 2 diabetes.
    Ryan GJ; Jobe LJ
    J Pharm Pract; 2011 Jun; 24(3):316-22. PubMed ID: 21676855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone deficiency: a risk factor for cardiovascular disease?
    Jones TH
    Trends Endocrinol Metab; 2010 Aug; 21(8):496-503. PubMed ID: 20381374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
    Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relevant clinical and biological criteria for the diagnosis of androgen deficiency in the aging male (ADAM)].
    Seisen T; Rouprêt M; Gallais JL; Costa P
    Prog Urol; 2012 Jun; 22 Suppl 1():S21-6. PubMed ID: 22770497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI; Huhtaniemi I
    Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study.
    Corona G; Rastrelli G; Monami M; Guay A; Buvat J; Sforza A; Forti G; Mannucci E; Maggi M
    Eur J Endocrinol; 2011 Nov; 165(5):687-701. PubMed ID: 21852391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
    Saad F
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():52-9. PubMed ID: 23280867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic syndrome and hypogonadism. Testosteron may protect the heart in type 2 diabetes mellitus].
    Schaaf L
    MMW Fortschr Med; 2015 Sep; 157(15):65-7. PubMed ID: 26349733
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correction of androgen deficiency in elderly patients].
    Morgunov LIu
    Klin Med (Mosk); 2007; 85(9):17-22. PubMed ID: 18038561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypogonadotropic hypogonadism in men with type 2 diabetes.
    Dandona P; Dhindsa S; Chandel A; Chaudhuri A
    Postgrad Med; 2009 May; 121(3):45-51. PubMed ID: 19491539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.